[Congressional Record Volume 145, Number 4 (Tuesday, January 12, 1999)]
[Daily Digest]
[Page D17]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

Committee Meetings
(Committees not listed did not meet)
STEM CELL RESEARCH AND DEVELOPMENT
Committee on Appropriations: Subcommittee on Labor, Health and Human 
Services, Education and Related Agencies held hearings to examine the 
scientific implications of stem cell research and development, focusing 
on patent and technology transfer implications and how intellectual 
property consideration affect basic science and the future development 
of products for public benefits, receiving testimony from Q. Todd 
Dickinson, Acting Assistant Secretary of Commerce, and Acting 
Commissioner of Patents and Trademarks; Maria C. Freire, Director, 
Office of Technology Transfer, National Institute of Health, Department 
of Health and Human Services; Lawrence S.B. Goldstein, University of 
California, San Diego School of Medicine, on behalf of the American 
Society for Cell Biology; Doug Melton, Harvard University, Cambridge, 
Massachusetts, on behalf of the Juvenile Diabetes Foundation 
International; and Richard L. Pikunis, Jr., Marlton, New Jersey.
  Hearings were recessed subject to call.